A Randomized Combination Chemotherapy Trial, with and without Adriamycin, in Squamous Cell Carcinoma of the Head and Neck

One hundred seventeen patients with advanced squamous cell carcinoma of the head and neck were treated and placed randomly between two combination protocols, one with adriamycin and the other without. Responses (more than 50% tumor regression) were 67% overall with 63% responding to the combination without adriamycin and 82% responding to the protocol containing it. The increase in the response rate seen with the addition of adriamycin was not statistically significant. The degree of response to chemotherapy was reduced by prior radiotherapy.

[1]  B. Hill,et al.  A kinetically based logical approach to the chemotherapy of head and neck cancer. , 1977, Clinical otolaryngology and allied sciences.

[2]  J. Goldie,et al.  20-hour combination chemotherapy in advanced breast cancer. , 1977, British medical journal.

[3]  B. Sikjaer,et al.  Bronchial biopsies after belcomethasone dipropionate aerosol. , 1977, British journal of diseases of the chest.

[4]  G. Thomas,et al.  Treatment of advanced bronchogenic carcinoma with adriamycin, 5-fluorouracil and methotrexate. , 1977, British journal of diseases of the chest.

[5]  L. A. Price,et al.  INTENSIVE CANCER CHEMOTHERAPY , 1976, The Lancet.

[6]  HOW STRONG IS THE CASE FOR INTENSIVE CANCER CHEMOTHERAPY? , 1976, The Lancet.

[7]  B. Hill,et al.  The cell cycle and its significance for cancer treatment. , 1975, Cancer treatment reviews.

[8]  B. Hill,et al.  Letter: Kinetic classifications of Antitumour Drugs. , 1975, British medical journal.

[9]  B. Hill,et al.  Kinetically-based multiple drug treatment for advanced head and neck cancer. , 1975, British medical journal.

[10]  J. Bertino,et al.  Bleomycin therapy in advanced Hodgkin's disease and epidermoid cancers , 1972, Cancer.

[11]  J. Goldie,et al.  Multiple Drug Therapy for Disseminated Malignant Tumours , 1971, British medical journal.

[12]  G. Westbury,et al.  Seventy-Five Cases of Solid Tumours Treated by a Modified Quadruple Chemotherapy Regime , 1971, British Journal of Cancer.

[13]  J. Matthias.  Chemotherapy of cancer of the gut. , 1971, The Practitioner.

[14]  C. Nervi,et al.  [Regional hyperoxygenation: an important factor in the potentiation of antineoplastic chemotherapy]. , 1969, Tumori.

[15]  M. Weil,et al.  [Polychemotherapy of cancer. Preliminary study concerning 82 cases, of which 76 are cases of cancer of stomatologic origin]. , 1967, La Presse medicale.

[16]  W. R. Bruce,et al.  Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents Administered In Vivo , 1966 .